U.S. Non-alcoholic Steatohepatitis Biomarkers (Serum, Hepatic Fibrosis, Apoptosis) Market Research 2024-2030: Increasing Prevalence of Obesity, Type 2 Diabetes, and Metabolic Syndrome Fueling Demand
July 24, 2024 09:15 ET
|
Research and Markets
Dublin, July 24, 2024 (GLOBE NEWSWIRE) -- The "U.S. Non-alcoholic Steatohepatitis Biomarkers Market Size, Share & Trends Analysis Report by Type (Serum, Hepatic Fibrosis, Apoptosis), End-use...
Insights on the Non-Alcoholic Steatohepatitis (NASH) Biomarker Global Market to 2028 - by Type, Industry Verticals and Region
May 05, 2021 04:43 ET
|
Research and Markets
Dublin, May 05, 2021 (GLOBE NEWSWIRE) -- The "Global Non-Alcoholic Steatohepatitis (NASH) Biomarker Market 2021-2028" report has been added to ResearchAndMarkets.com's offering. According to this...